YCW21· OtherValink Therapeutics
Discovering bispecific antibody drug-conjugates (BsADC) against cancer
Founders
Not read from YC yet; the weekly run fills these in.
Same space
Competitors
Closest in what they build, same category.
Eris BiotechW24Our drugs engage the immune system to fight tumorsShared: biotech, therapeutics, drug discoveryActive
Sequence BioS19Discovering the true signals of disease to power life-changing drugs.Shared: therapeutics, drug discoveryActive
AlixiaW22Targeting the Tumor Ecosystem to address cancer drug resistance.Shared: biotech, therapeutics, drug discoveryActive
Gerostate AlphaS18Developing novel therapeutics for aging and chronic diseaseShared: biotech, therapeuticsInactive
SynsoryBioW24"If-then" conditional logic for protein drugsShared: biotech, therapeuticsActive
Adjacent
Overlapping tags, a different niche.
Velorum TherapeuticsW24Breakthrough medicines unlocking the biology of hemeShared: biotech, therapeutics, drug discoveryActive
Adventris PharmaceuticalsW23Adventris makes cancer vaccinesShared: biotech, therapeutics, drug discoveryActive
ParcelBioW24Elevated mRNA for transformative medicines.Shared: biotech, therapeutics, drug discoveryActive
Altay TherapeuticsW20Altay develops disease-modifying therapies targeting transcription…Shared: biotech, therapeutics, drug discoveryActive
Origami Therapeutics, Inc.W22Oral drugs to halt neurodegenerationShared: biotech, therapeutics, drug discoveryActive
Also from W21
Batchmates in Winter 2021.
AbacumW21The AI-native FP&A platform that helps Finance teams drive business…Active
AlineaW21Automated investing for the next generation 💸Active
AlokaiW21Frontend Platform for eCommerceActive
AnimaW21The next generation care enablement platformActive
arnataW21AI workers for the logistics industry.Active
ArpioW21Recover from any outage in 10 minutes or less.Active
About Valink Therapeutics
Valink Therapeutics develops next generation antibody-based therapeutics. We identify novel mechanism of action from known targets by incorporating multiple antibody modifications at once, rapidly and scalable generating complex drug candidates (bi-/multispecificity, multivalency and drug-conjugation in a single discovery process). Our research focus is on solid tumours poorly addressed by immunotherapy.
Boston, MA, USA
Valink Therapeutics: questions
Which YC batch was Valink Therapeutics in?
Valink Therapeutics was in Y Combinator's Winter 2021 batch (W21).
Is Valink Therapeutics still active?
Y Combinator lists Valink Therapeutics as active.
Where is Valink Therapeutics based?
Valink Therapeutics lists Boston, MA, USA as its location on YC's directory.
Not affiliated with Y Combinator. From YC's public directory. Logos via logo.dev; trademarks belong to their owners.